Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-003589-25Phase 4Completed
Phase 4, randomised trial in acute kidney failure (AKF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Change in glomerular filtration rate. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-003589-25.